Kennedy Krieger Institute

Summary

Kennedy Krieger Institute is a medical facility located in Baltimore, Maryland. This center is recognized for care of Autism Spectrum Disorder, Duchenne Muscular Dystrophy, Autism, Attention-Deficit/Hyperactivity Disorder (ADHD), Attention Deficit Hyperactivity Disorder (ADHD) and other specialties. Kennedy Krieger Institute is involved with conducting 146 clinical trials across 250 conditions. There are 10 research doctors associated with this hospital, such as Doris Leung, MD, Dejan Budimirovic, MD, Genila Bibat, MD, and Rebecca Landa, PhD, CCC-SLP.

Top PIs

Clinical Trials running at Kennedy Krieger Institute

Autism Spectrum Disorder

Facioscapulohumeral Muscular Dystrophy

Adrenoleukodystrophy

Facioscapulohumeral muscular dystrophy

Rett Syndrome

Cerebral Palsy

Autism

Leukoencephalopathy

Intellectual Disability

Genetic Disorders

Suicide Prevention Interventions

for Autism

This trial is testing two methods to prevent suicide in autistic youth aged 12-24. One method involves creating a personalized safety plan, while the other adds ongoing support through periodic check-ins. The safety plan helps individuals recognize warning signs and use coping strategies, and the check-ins provide continuous support.

Recruiting

1 award

N/A

5 criteria

Reinforcement Strategies

for Intellectual Disabilities

This study is designed to better understand how certain features of reinforcement affect learning and motivation in individuals with intellectual and developmental disabilities (IDD). Participants will take part in a series of structured teaching sessions that involve simple tasks and reward-based feedback. By changing the timing and amount of rewards, we aim to learn how these factors influence the ability to acquire and maintain new skills. This information may help improve behavioral interventions for individuals with IDD in the future. The study does not involve medications or procedures intended to change participants' health status.

Recruiting

1 award

N/A

1 criteria

Cognitive Behavioral Therapy + Psychoeducation

for Anxiety in Children With Autism

Anxiety is prevalent in young children, under 7 years of age, with autism. Yet, few studies have examined anxiety interventions for this age range, and only one anxiety treatment study has included young children with cognitive and language delays. Anxiety treatment models utilizing cognitive-behavioral therapy (CBT), adapted for children with autism, are empirically supported in school-age autistic children. Further, preliminary evidence suggests CBT approaches may reduce intolerance of uncertainty (IU), a mechanistic construct that may contribute to the maintenance of anxiety in autistic children. This study seeks to address the existing gap in anxiety treatment by examining the feasibility and preliminary efficacy of a novel, telehealth CBT intervention, DINO Strategies for Anxiety and intolerance of Uncertainty Reduction (DINOSAUR), which targets both anxiety and IU in young autistic children.

Recruiting

1 award

N/A

8 criteria